Apollo Hospitals Q2 FY27 Results: Profit Up, Divestment Complete, New CEO Appointed
Apollo Hospitals reported unaudited results for Q2 FY27. Dr. Ritu Garg was appointed CEO of multiple regions. Dr. Madhu Sasidhar will cease as President & CEO of Hospitals Division on Nov 14, 2026. The divestment of Apollo Specialty Hospitals and Apollo Fertility Centre to KCIL is complete, with Apollo Hospitals receiving a 9.9% stake in KCIL.
The financial results, significant divestment completion, and senior management changes are material events that will likely impact investor perception and the company's strategic direction.
The company reported positive financial results and completed a strategic divestment, along with key management appointments, indicating forward momentum.
Apollo Hospitals Enterprise Limited announced its unaudited standalone and consolidated financial results for the three and six months ended September 30, 2026. The Board of Directors approved these results, which have undergone a limited review by the Statutory Auditors. The company also announced changes in Senior Management Personnel, with Dr. Ritu Garg appointed as Chief Executive Officer for multiple regions. Dr. Madhu Sasidhar will cease to hold the position of President & CEO - Hospitals Division, effective November 14, 2026. The company also reported the completion of the divestment by its wholly-owned subsidiary, Apollo Health and Lifestyle Limited (AHLL), of its entire shareholding in Apollo Specialty Hospitals Private Limited and Apollo Fertility Centre Private Limited to Kids Clinic India Limited (KCIL). AHLL received the agreed consideration and has been allotted securities representing an effective 9.9% equity stake in KCIL. The transaction was envisaged at an enterprise value of approximately ₹11,500 million, comprising cash consideration of ₹7,650 million and an equity stake in KCIL valued at ₹3,850 million. The financial results and Limited Review Reports will be made available on the company's website.
What to do with a filing like this
Apollo Hospitals Enterprise Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Apollo Hospitals Enterprise Limited. Read the original for the full detail.